dilazep has been researched along with ADPKD in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with dilazep was continued for a period of 6 months, at the end of which the UAE was reduced form 130 +/- 52 to 46 +/- 26 microg/min (p < 0." | 2.70 | Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease. ( Ebihara, I; Koide, H; Nakamura, T; Shimada, N; Takahashi, Y; Tanaka, A; Ushiyama, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, T | 1 |
| Ushiyama, C | 1 |
| Takahashi, Y | 1 |
| Tanaka, A | 1 |
| Shimada, N | 1 |
| Ebihara, I | 1 |
| Koide, H | 1 |
1 trial available for dilazep and ADPKD
| Article | Year |
|---|---|
Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease.
Topics: Albuminuria; Dilazep; Female; Humans; Hypertension, Renal; Male; Middle Aged; Polycystic Kidney, Aut | 2001 |